<DOC>
	<DOCNO>NCT02560857</DOCNO>
	<brief_summary>The study prospectively determine clinical utility non-pathogen specific cellular immunity assessment use Quantiferon-Monitor quantify degree immunosuppression . The investigator use result assay predict whether patient develop opportunistic infection predict organ rejection .</brief_summary>
	<brief_title>Clinical Evaluation Quantiferon-Monitor Predict Outcomes Solid Organ Transplant Recipients</brief_title>
	<detailed_description>Solid organ transplant ( SOT ) recipients undergo life-long immunosuppression prevent allograft rejection . However , also put patient significant risk opportunistic infection . The degree immunosuppression varies individual likely influence combination clinical factor antirejection medication , comorbidities , patient age well state patient immune system . Thus far , standardized method quantify degree global immunosuppression . A new blood test ( Quantiferon-Monitor ) recently develop might help predict level immune suppression . The purpose study determine whether new test help determine person 's level immune suppression organ transplant . This do try relate level immunity development infection rejection . If test immunosuppression helpful , may help u good take account difference patient design therapy . Ultimately , may help develop good way prevent infection transplant rejection .</detailed_description>
	<criteria>Adult SOT recipient least one immunosuppressive medication able comply protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Quantiferon-Monitor</keyword>
	<keyword>organ rejection</keyword>
	<keyword>global immunity</keyword>
</DOC>